Content

BARDA at BTEC Overview

The Golden LEAF Biomanufacturing Training and Education Center (BTEC) at NC State University provides training for selected employees of global influenza vaccine manufacturers. Countries that have participated in this program include Brazil, Egypt, India, Indonesia, Kazakhstan, Mexico, Romania, Russia, Serbia, South Africa, South Korea, Thailand, and Vietnam. Funding for this program comes from the U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA). In addition, the World Health Organization (WHO) underwrites the participation of individuals associated with national regulatory authorities.

Course Offerings

Image of BTEC facility
Find out more about the program: go.ncsu.edu/barda-video

BTEC will offer the Fundamentals of cGMP Influenza Vaccine Manufacturing course twice during 2015:

  • April 27 through May 15 for employees of participating vaccine manufacturers
  • June 1–19 for personnel employed by national regulatory authorities

The GTI is proud to partner with BTEC on this important global health program and will provide and arrange logistical services (participant selection, transportation, visa documentation, orientation, housing, meals, cultural programs, etc.) for BTEC and the BARDA program participants.

Information for Training Candidates

All candidates must meet the following criteria:

  • Fluent in English (able to read, write, speak, and understand spoken English).
  • Currently employed by an institution receiving support from BARDA and/or WHO for the international vaccine production capacity-building program.
  • Have a background in biological sciences or engineering and/or experience in the manufacturing of vaccines or biologicals

Application Process - December 31, 2014 is the deadline to apply

1. Complete the BARDA application online (go.ncsu.edu/BARDA_app). There are 2 parts to the application process. Part 1 includes filling out some biographical information and uploading the following documents:

  • Your most current Curriculum Vitae (CV)
  • The biographical page from your passport (see image below)
  • Sample Passport Bio Page

2. You will automatically be redirected to a background survey after you complete part 1. Completing the background survey is part 2 of the application process. The background survey consists of 43 questions related to your familiarity with the training topic. If you need to access the survey at a later point in time, you can find it at http://go.ncsu.edu/barda2015.

3. If you are selected for the 2015 BARDA at BTEC program, we will notify you by email and provide you further information about the visa application process.

BTEC facility Image of BTEC exterior Image of NC State campus

Find the answers to the Frequently Asked Questions (FAQ) for BARDA participants

Pre-arrival information for BARDA participants

Guide for BARDA participants coming to NC State

Contact Information

BTEC (for training content)
Dr. Jennifer Ruiz, Assistant Director, Bioprocess Services and BARDA training program manager
Phone: 919.515.0215
Email: jennifer_ruiz@ncsu.edu

GTI (for logistics)
Mr. Michael Bustle, GTI Director
Ilin Misaras, GTI Assistant Director
Phone: 919.513.0105
Email: gti@ncsu.edu

BARDA and BTEC Background

Beginning in September 2010, BTEC has received annual grant awards as part of a five-year, nearly $5 million project funded by the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services. The grant funding has enabled a team of instructors from BTEC, Duke University, and industry to provide training to 130 individuals to date. Participants have completed one or more of the three different courses—the Fundamentals of cGMP Influenza Vaccine Manufacturing course, Advanced Upstream Processing and Advanced Downstream Processing. Since 2011, the Fundamentals course has been offered six times, while each of the Advanced courses have been offered twice. Trainees were selected by institutions participating in the U.S. government-sponsored program to build vaccine production capacity among countries with developing economies.